tiprankstipranks
Advertisement
Advertisement
Natera price target raised to $220 from $215 at Wells Fargo
PremiumThe FlyNatera price target raised to $220 from $215 at Wells Fargo
23h ago
Natera: Strong Q1 Beat, Raised Guidance Support Buy Rating with Unchanged $280 Price Target
Premium
Ratings
Natera: Strong Q1 Beat, Raised Guidance Support Buy Rating with Unchanged $280 Price Target
1d ago
Natera reports Q1 EPS -60c, consensus -55c
Premium
The Fly
Natera reports Q1 EPS -60c, consensus -55c
2d ago
Natera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion
PremiumRatingsNatera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion
26d ago
Natera highlights Allogene Therapeutics’ analysis from ALPHA3 trial
Premium
The Fly
Natera highlights Allogene Therapeutics’ analysis from ALPHA3 trial
26d ago
Natera awarded 30% ongoing royalty for MRD-related patents
Premium
The Fly
Natera awarded 30% ongoing royalty for MRD-related patents
1M ago
Natera announces publications on clinical utility of Signatera
PremiumThe FlyNatera announces publications on clinical utility of Signatera
2M ago
GeneDx data could support improved coverage, says Craig-Hallum
Premium
The Fly
GeneDx data could support improved coverage, says Craig-Hallum
2M ago
Natera announces commercial launch of Zenith genomics
Premium
The Fly
Natera announces commercial launch of Zenith genomics
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100